Lead party: SPE Capital Partners (lead investor/buyer)
Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).
Target: Orchidia Pharmaceutical Industries S.A.E. (private company) · Sector: Healthcare, Pharmaceuticals · Countries of operation: Egypt
Transaction type: Investment · Asset class: Private Equity · Strategy: Growth Equity · Instrument: Equity · Fund: SPE Africa Industrialisation Fund I
Lead investor/buyer: SPE Capital Partners · Investors/buyers: SPE Capital Partners
Legal advisers: not identified in the source record.
Source: announced 1 January 2013. Original announcement: spe-capital.com.


